Ottobock SE & Co. KGaA

Research Ottobock SE & Co. KGaA (OBCK) on Bullrun: valuation model: 4.0% overvalued, market cap EUR 3.28B, P/E 35.7, dividend yield 1.9%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

Bullrun's latest valuation model marks Ottobock SE & Co. KGaA as 4.0% overvalued; latest market cap is EUR 3.28B; P/E is 35.7; dividend yield is 1.9%.

About Ottobock SE & Co. KGaA

Ottobock SE & Co. KGaA develops, produces, and distributes medical technology products and components for the people with disabilities in the fields of prosthetics, orthotics, human mobility, and industrial exoskeletons in Europe, the Middle East, Africa, North and South America, and the Asia Pacific. The company is involved in identification, development, manufacturing, sales, and marketing of prosthetics, neuro-orthotics, and digital solutions; prostheses for the upper and lower extremities;

Frequently asked questions

Is Ottobock SE & Co. KGaA overvalued or undervalued?

Bullrun's valuation model currently marks Ottobock SE & Co. KGaA as 4.0% overvalued.

What is Ottobock SE & Co. KGaA's market cap?

Ottobock SE & Co. KGaA's market capitalization is EUR 3.28B.

What is Ottobock SE & Co. KGaA's P/E ratio?

Ottobock SE & Co. KGaA's price-to-earnings (P/E) ratio is 35.7.

Does Ottobock SE & Co. KGaA pay a dividend?

Ottobock SE & Co. KGaA has a dividend yield of 1.9%.

What does Ottobock SE & Co. KGaA do?

Ottobock SE & Co. KGaA develops, produces, and distributes medical technology products and components for the people with disabilities in the fields of prosthetics, orthotics, human mobility, and industrial exoskeletons in Europe, the Middle East, Africa, North and South America, and the Asia...